Search

Your search keyword '"Sharma, Raman"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Sharma, Raman" Remove constraint Author: "Sharma, Raman" Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
72 results on '"Sharma, Raman"'

Search Results

16. Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention.

18. Pharmacotherapy and revascularization strategies of peripheral artery disease.

19. Resistivity of a 2d quantum critical metal.

20. Harnessing biosynthesis and quantitative NMR for late stage functionalization of lead molecules: Application to the M1 positive allosteric modulator (PAM) program.

21. Euler-Euler CFD simulation of the fuel reactor of a 1 MWth chemical-looping pilot plant: Influence of the drag models and specularity coefficient.

23. O-Aryl α,β-d-ribofuranosides: Synthesis & highly efficient biocatalytic separation of anomers and evaluation of their Src kinase inhibitory activity

24. Intrinsic electrophilicity of the 4-methylsulfonyl-2-pyridone scaffold in glucokinase activators: Role of glutathione-S-transferases and in vivo quantitation of a glutathione conjugate in rats

25. Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols

26. Differences in CYP3A4 catalyzed bioactivation of 5-aminooxindole and 5-aminobenzsultam scaffolds in proline-rich tyrosine kinase 2 (PYK2) inhibitors: Retrospective analysis by CYP3A4 molecular docking, quantum chemical calculations and glutathione adduct detection using linear ion trap/orbitrap mass spectrometry

29. Plumbene: A next generation hydrogen storage medium.

30. A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week.

33. IMPACT OF POTENT P2Y12 INHIBITOR USE VERSUS CLOPIDOGREL IN REAL-WORLD PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY.

34. RISK-TREATMENT PARADOX IN PREVALENCE AND DETERMINANTS OF POTENT P2Y12 INHIBITOR USE IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY.

36. PROVISIONAL VS TWO-STENT STRATEGY IN THE TREATMENT OF TRUE BIFURCATION CORONARY LESIONS: OUTCOMES STRATIFIED BY LESION COMPLEXITY.

37. A NOVEL RISK SCORE TO PREDICT ONE-YEAR RISK OF MACE IN PATIENTS UNDERGOING CORONARY TRUE BIFURCATION INTERVENTION.

38. CLINICAL IMPACT OF PROCEDURAL COMPLEXITY AND HIGH BLEEDING RISK STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.

39. IMPACT OF LEFT VENTRICULAR EJECTION FRACTION ON 1-YEAR OUTCOMES IN PATIENTS WITH END-STAGE RENAL DISEASE FOLLOWING PERCUTANEOUS CORONARY INTERVENTION.

40. IMPACT OF POLYVASCULAR DISEASE ON MORTALITY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE.

41. OUTCOMES OF PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION STRATIFIED BY TREATMENT WITH OR WITHOUT GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONISTS.

42. INFLAMMATION AND CONTRAST ASSOCIATED ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.

43. TCT-652 Real-World Comparison of Clopidogrel With Ticagrelor and Prasugrel in Patients With Chronic Coronary Disease Undergoing Atherectomy.

44. Managing sodic soils for better productivity and farmers' income by integrating use of salt tolerant rice varieties and matching agronomic practices.

45. TCT-749 Predictors of Suboptimal Stent Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis: Insights From Intravascular Imaging.

46. Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malaria.

47. TICAGRELOR OR PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC CORONARY SYNDROMES: RESULTS FROM A REAL-WORLD REGISTRY.

48. SYNERGISTIC USE OF ROTATIONAL ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY AS A CALCIUM MODIFICATION STRATEGY IN HEAVILY CALCIFIED, LARGE CALIBER CORONARY ARTERIES.

50. Optimization of amide-based EP3 receptor antagonists.

Catalog

Books, media, physical & digital resources